Cell-Based Therapies for Traumatic Brain Injury: Therapeutic Treatments and Clinical Trials.

ABSTRACT: Traumatic brain injury (TBI) represents physical damage to the brain tissue that induces transitory or permanent neurological disabilities. TBI contributes to 50% of all trauma deaths, with many enduring long-term consequences and significant medical and rehabilitation costs. There is currently no therapy to reverse the effects associated with TBI. An increasing amount of research has been undertaken regarding the use of different stem cells (SCs) to treat the consequences of brain damage. Neural stem cells (NSCs) (adult and embryonic) and mesenchymal stromal cells (MSCs) have shown efficacy in pre-clinical models of TBI and in their introduction to clinical research. The purpose of this review is to provide an overview of TBI and the state of clinical trials aimed at evaluating the use of

SUBMITTER: Bonilla C 

PROVIDER: S-EPMC8230536 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature